MANUAL, a digital healthcare provider, has secured $120.0 million in new investment capital from investors. This significant funding round will support the company's mission to deliver comprehensive healthcare at scale through its digital clinic, focusing on extending healthy years for individuals in the UK, Brazil, and other markets.
The company specializes in addressing life-impeding conditions such as hormonal imbalance, obesity, and hair loss. MANUAL centralizes the entire patient journey, integrating diagnosis, custom medications, specialist doctor services, behavioral change programs, and vertically integrated treatment management under one digital roof. This innovative approach to healthcare delivery aims to provide engaging treatment plans that generate superior clinical outcomes, with over 90% of patients reportedly experiencing an improvement in their Quality of Life within six months.
This latest capital infusion builds on MANUAL's steady growth since its inception, having previously raised $30 million. The company currently serves over 500,000 patients across two geographies. The newly raised $120.0 million is earmarked to accelerate MANUAL's expansion, with plans to use the funds for growth initiatives, including further developing its digital clinic offerings, enhancing its technology platform, and potentially extending its reach into new geographical markets.
The investment underscores confidence in MANUAL's model for scalable healthcare delivery. Looking ahead, the company aims to continue its trajectory of growth, broaden its impact on patient health, and further solidify its position as a leader in digital healthcare solutions for chronic and life-impeding conditions.
